The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
Irene Biasoli
Scientific Advisory Board Member
Irene Biasoli, MD, is an Associate Professor of Hematology in the Internal Medicine Department at the Federal University of Rio de Janeiro, Rio de Janeiro, BR.
She graduated in medicine in 1993 and obtained her specialization in hematology in 1997 from Federal University of Rio de Janeiro. She obtained her MSc in 1999 and PhD in 2004 at the same institution, where she has continued her clinical and research activity. In 2007, she was a postdoctoral researcher in Hôpital St Louis, Paris, FR.
Currently, she coordinates the Brazilian Hodgkin Lymphoma Registry. She is author/co-author of over 35 peer-reviewed papers. Her clinical research interests are focused on lymphoproliferative disorders.
Filter by content: